Importer of Controlled Substances Notice of Application; ISP Freetown Fine Chemicals, 40910-40911 [2012-16920]
Download as PDF
<![CDATA[
40910
Federal Register / Vol. 77, No. 133 / Wednesday, July 11, 2012 / Notices
RESPONDENTS’ ESTIMATED ANNUAL BURDEN HOURS—Continued
30 CFR Section
Reporting and recordkeeping requirements
Hour burden
per response
Number of
annual
responses
srobinson on DSK4SPTVN1PROD with NOTICES
TOTAL BURDEN .......................................................................................................................................
Estimated Annual Reporting and
Recordkeeping ‘‘Non-hour’’ Cost
Burden: We have identified no ‘‘nonhour cost’’ burden associated with this
collection of information.
Public Disclosure Statement: The PRA
(44 U.S.C. 3501 et seq.) provides that an
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number.
Comments: Section 3506(c)(2)(A) of
the PRA requires each agency to ‘‘* * *
provide 60-day notice in the Federal
Register * * * and otherwise consult
with members of the public and affected
agencies concerning each proposed
collection of information * * *.’’
Agencies must specifically solicit
comments to (a) evaluate whether the
proposed collection of information is
necessary for the agency to perform its
duties, including whether the
information is useful; (b) evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information; (c) enhance the quality,
usefulness, and clarity of the
information that ONRR collects; and (d)
minimize the burden on the
respondents, including the use of
automated collection techniques or
other forms of information technology.
To comply with the public
consultation process, we published a
notice in the Federal Register on
February 2, 2012 (77 FR 5268),
announcing that we would submit this
ICR to OMB for approval. The notice
provided the required 60-day comment
period. We received no unsolicited
comments in response to the notice.
If you wish to comment in response
to this notice, you may send your
comments to the offices listed under the
ADDRESSES section of this notice. OMB
has up to 60 days to approve or
disapprove the information collection,
but they may respond after 30 days.
Therefore, in order to ensure maximum
consideration, OMB should receive
public comments by August 10, 2012.
Public Comment Policy: We post all
comments, including names and
addresses of respondents, at https://
www.regulations.gov. Before including
your address, phone number, email
address, or other personal identifying
information in your comment, be
VerDate Mar<15>2010
18:11 Jul 10, 2012
Jkt 226001
advised that we may make publicly
available at any time your entire
comment—including your personal
identifying information. While you can
ask us in your comment to withhold
from public view your personal
identifying information, we cannot
guarantee that we will be able to do so.
Information Collection Clearance
Officer: Laura Dorey (202) 208–2654.
Dated: June 21, 2012.
Gregory J. Gould,
Director, Office of Natural Resources
Revenue.
[FR Doc. 2012–16922 Filed 7–10–12; 8:45 am]
BILLING CODE 4310–T2–P
Annual burden
hours
462
5,519
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–363]
Controlled Substances: Proposed
Adjustment to the Aggregate
Production Quotas for 2012
In notice document 2012–16396
appearing on pages 39737–38741 in the
issue of Thursday, July 5, 2012, make
the following correction:
On page 39739, in the table, in the
second line from the bottom of the page,
the third column should read ‘‘No
Change.’’
[FR Doc. C1–2012–16396 Filed 7–10–12; 8:45 am]
BILLING CODE 1505–01–D
INTERNATIONAL TRADE
COMMISSION
DEPARTMENT OF JUSTICE
[USITC SE–12–017]
Drug Enforcement Administration
Sunshine Act Meeting
Importer of Controlled Substances
Notice of Application; ISP Freetown
Fine Chemicals
United
States International Trade Commission.
TIME AND DATE: July 17, 2012 at
11:00 a.m.
PLACE: Room 100, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: none.
2. Minutes.
3. Ratification List.
4. Vote in Inv. Nos. 731–TA–678–679
and 681–682 (Third Review) (Stainless
Steel Bar from Brazil, India, Japan, and
Spain). The Commission is currently
scheduled to transmit its determinations
and Commissioners’ opinions to the
Secretary of Commerce on or before July
26, 2012.
5. Outstanding action jackets: none.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
AGENCY HOLDING THE MEETING:
Issued: July 9, 2012.
By order of the Commission.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2012–17056 Filed 7–9–12; 4:15 pm]
BILLING CODE 7020–02–P
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on April 30, 2012, ISP Freetown
Fine Chemicals, 238 South Main Street,
Assonet, Massachusetts 02702, made
application by renewal to the Drug
Enforcement Administration (DEA) for
registration as an importer of
Phenylacetone (8501), a basic class of
controlled substance listed in schedule
II.
The company plans to import the
controlled substance to manufacture
amphetamine.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act 21 U.S.C.
952 (a)(2)(B) may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43, and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
E:\FR\FM\11JYN1.SGM
11JYN1
Federal Register / Vol. 77, No. 133 / Wednesday, July 11, 2012 / Notices
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than August 10, 2012.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745–46, all applicants for
registration to import a basic class of
any controlled substance in schedules I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: July 2, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–16920 Filed 7–10–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application; United States
Pharmacopeial Convention
Pursuant to Title 21 Code of Federal
Regulations 1301.34 (a), this is notice
that on February 17, 2012, United States
Pharmacopeial Convention, 12601
Twinbrook Parkway, Rockville,
Maryland 20852, made application by
renewal to the Drug Enforcement
Administration (DEA) for registration as
an importer of the following basic
classes of controlled substances:
srobinson on DSK4SPTVN1PROD with NOTICES
Drug
Schedule
Cathinone (1235) ..........................
Methaqualone (2565) ...................
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
4-Methyl-2,5dimethoxyamphetamine (7395).
3,4-Methylenedioxyamphetamine
(7400).
Codeine-N-oxide (9053) ...............
Heroin (9200) ...............................
Morphine-N-oxide (9307) .............
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Phenmetrazine (1631) ..................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
VerDate Mar<15>2010
18:11 Jul 10, 2012
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
Jkt 226001
Schedule
Drug
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Phencyclidine (7471) ....................
4-Anilino-N-phenethyl-4-piperidine
(8333).
Phenylacetone (8501) ..................
Alphaprodine (9010) .....................
Anileridine (9020) .........................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
21 CFR 1301.34(b), (c), (d), (e), and (f)
are satisfied.
II
II
II
II
Dated: July 2, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import
reference standards for sale to
researchers and analytical labs.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act 21 U.S.C. 952
(a)(2)(B) may, in the circumstances set
forth in 21 U.S.C. 958(i), file comments
or objections to the issuance of the
proposed registration and may, at the
same time, file a written request for a
hearing on such application pursuant to
21 CFR 1301.43, and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than August 10, 2012.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745–46, all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to
21 U.S.C. 958(a); 21 U.S.C. 823(a); and
PO 00000
Frm 00066
Fmt 4703
40911
Sfmt 4703
[FR Doc. 2012–16918 Filed 7–10–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
National Institute of Corrections
Solicitation for a Cooperative
Agreement—Technical Assistance Site
Management in NIC’s Evidence-Based
Decision Making in Local Criminal
Justice Systems Initiative
National Institute of
Corrections, U.S. Department of Justice.
ACTION: Solicitation for a Cooperative
Agreement.
AGENCY:
The National Institute of
Corrections (NIC) Community Services
Division is soliciting proposals from
organizations, groups, or individuals to
enter into a cooperative agreement with
NIC for up to 16 months beginning in
August 2012. Work under this
cooperative agreement is part of a larger
NIC initiative, Evidence-Based Decision
Making (EBDM) in Local Criminal
Justice Systems. Work under this
cooperative agreement will be
coordinated with awardees of other
cooperative agreements who will be
providing services under Phase III of
this initiative.
Specifically, under this cooperative
agreement, the awardee will provide
technical assistance to seven Phase III
sites that have already been identified.
During Phase II of the EBDM initiative,
the seven sites identified change
strategies based on their individual
system planning activities. These
change strategies are critical to meeting
their system’s harm reduction goals. The
technical assistance from this award
will be targeted to the identified change
strategies.
DATES: Applications must be received
by 4 p.m. (EDT) on Friday, July 30,
2012.
SUMMARY:
Mailed applications must be
sent to: Director, National Institute of
Corrections, 320 First Street NW., Room
5002, Washington, DC 20534.
Applicants are encouraged to use
Federal Express, UPS, or similar service
to ensure delivery by the due date.
Hand delivered applications should
be brought to 500 First Street NW.,
Washington, DC 20534. At the front
ADDRESSES:
E:\FR\FM\11JYN1.SGM
11JYN1
]]>Agencies
[Federal Register Volume 77, Number 133 (Wednesday, July 11, 2012)]
[Notices]
[Pages 40910-40911]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-16920]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances Notice of Application; ISP
Freetown Fine Chemicals
Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on April 30, 2012, ISP Freetown Fine Chemicals, 238
South Main Street, Assonet, Massachusetts 02702, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as an importer of Phenylacetone (8501), a basic class of controlled
substance listed in schedule II.
The company plans to import the controlled substance to manufacture
amphetamine.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act 21 U.S.C. 952 (a)(2)(B) may, in the
circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43, and in such form as prescribed by 21 CFR
1316.47.
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement
[[Page 40911]]
Administration, Office of Diversion Control, Federal Register
Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia
22152; and must be filed no later than August 10, 2012.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, 40 FR 43745-46, all applicants
for registration to import a basic class of any controlled substance in
schedules I or II are, and will continue to be, required to demonstrate
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, that the requirements for such
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR
1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: July 2, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-16920 Filed 7-10-12; 8:45 am]
BILLING CODE 4410-09-P
